A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

March 26, 2025

Study Completion Date

August 12, 2025

Conditions
Atopic DermatitisAtopicDermatitisDermatologic DiseaseEczemaEczema Atopic DermatitisEczema, Atopic
Interventions
DRUG

Camoteskimab

Drug Product

DRUG

Placebo

Inactive substance

Trial Locations (35)

19103

Paddington Testing Co. Inc, Philadelphia

27103

ObjectiveHealth-The Skin Surgery Center for Clinical Research, Winston-Salem

27612

M3 Wake Research, Inc., Raleigh

28329

Michigan Dermatology Institute, Waterford

33155

D&H National Research Centers, Inc., Miami

33613

Avita Clinical Research - Dermatology, Tampa

33991

Renaissance Research and Medical Group, Cape Coral

40217

Skin Sciences, PLLC, Louisville

42303

Owensboro Dermatology Associates, Owensboro

46250

Dawes Fretzin Clinical Research, Indianapolis

48084

Revival Research Institute, Troy

Somerset Skin Centre, Troy

61761

Sneeze, Wheeze & Itch Associates, LLC, Normal

64506

Advanced Dermatology and Skin Cancer Center - Saint Joseph, Saint Joseph

68144

Skin Specialists PC, Omaha

73071

Central Sooner Research, Oklahoma City

73118

Unity Clinical Research - Dermatology, Oklahoma City

75034

Rodgers Dermatology, Frisco

77004

Center for Clinical Studies, Houston

77074

Clinical Trial Network, Houston

85006

Medical Dermatology Specialists, PC/US Dermatology Partners, Phoenix

90025

California Allergy and Asthma Medical Group, Los Angeles

90095

University of California Los Angeles Dermatology, Los Angeles

90404

Clinical Sciences Institute, Santa Monica

91324

Amicis Research Center (Northridge), Northridge

92024

California Dermatology & Clinical Research Institute, Encinitas

92161

VASDHS - Veterans Affairs San Diego Medical Center, San Diego

92708

First OC Dermatology Research, Inc., Fountain Valley

93030

Cura Clinical Research, Oxnard

94538

Center for Dermatology Clinical Research, Inc., Fremont

T5J 3S9

Youthful Image, Edmonton

T6W 0J5

Rejuvenation Dermatology Clinic Edmonton South, Edmonton

M8X 1Y9

Kingsway Clinical Research, Etobicoke

G1W 4R4

Clinique Medicale Saint-Louis, Québec

J1G 1X9

Clinique Dermatologique de Sherbrooke, Sherbrooke

Sponsors
All Listed Sponsors
lead

Apollo Therapeutics Ltd

INDUSTRY

NCT06436183 - A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter